# Time-Review Exit Shadow — Implementation Result

Implemented: 2026-09-03

## Outcome

The approved measure-only time-review pipeline is complete. PositionMonitor now
captures one immutable observation for an alpha position at its exact resolved
horizon, before the incumbent time stop. The existing horizon-shadow schedule
matures matched +5/+10-session outcomes. Neither ledger has a money-path
consumer, and the unconditional time stop remains active.

## What shipped

- `time-review-v1` deterministic classifier with fail-closed score, direction,
  profitability, high-water drawdown, initial-stop-distance, active-stop, and
  target vetoes.
- Exact position/session idempotency and immutable market-local observation and
  outcome ledgers.
- Matched incumbent-next-session versus +5/+10-session outcomes with benchmark
  return, MFE/MAE, retained-stop result, and replacement-candidate attribution.
- Upgrade Path counts only exact review sessions with both outcomes matured.
  Legacy daily one-day-extension rows remain visible context but cannot advance
  readiness.

## Production proof

- Migration `time_review_exit_shadow` applied to FinanceOS Supabase project
  `dionkikgdmlaotvtbnfr`.
- Both tables have RLS, owner-only SELECT policies, narrow grants, and UPDATE /
  DELETE rejection triggers.
- Rolled-back transaction proved observation insertion, duplicate-key refusal,
  outcome insertion, and both append-only guards; zero synthetic rows remained.
- Supabase security advisors reported no finding for either new table. The only
  table-specific performance notices were expected unused-index INFO notices on
  the still-empty observation ledger.

## Verification

- Mutation test: inverting the exact-horizon predicate failed three detectors.
- Focused: 26 tests passed.
- Full suite: 2,449 passed, 7 skipped.
- `tsc --noEmit`: passed.
- Isolated Next.js production build: passed.

## Still gated

No time-stop behavior changed. Twenty market sessions with exact reviews and
both outcomes only permits the next review. A sealed market-local portfolio
simulation with redeployment, costs, drawdown, turnover, multiple-trial control,
adverse-case review, and explicit owner approval remains mandatory before a
paper-policy change. Live use requires a separate approval.
